showed a trendp=0.03
( 45 ) A subgroup analysis among septic shock patients enrolled in the SAFE study showed a trend on mortality reduction in favor to albumin in comparison to normal saline (adjusted OR=0.71; 95%CI: 0.52-0.97; p=0.03).
( 45 ) A subgroup analysis among septic shock patients enrolled in the SAFE study showed a trend on mortality reduction in favor to albumin in comparison to normal saline (adjusted OR=0.71; 95%CI: 0.52-0.97; p=0.03).